Advertisement
U.S. markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.02-0.20 (-3.22%)
At close: 04:00PM EDT
6.10 +0.08 (+1.33%)
After hours: 07:34PM EDT
Advertisement
Show:
Annual
Upgrade to begin using 40 years of financial statements and get so much more.

Income Statement

All numbers in thousands
Upgrade to begin using 40 years of financial statements and get so much more.
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
258,215
258,215
154,080
80,943
42,220
Cost of Revenue
169,273
169,273
118,815
79,770
61,291
Gross Profit
88,942
88,942
35,265
1,173
-19,072
Operating Expense
67,310
67,310
74,630
59,547
45,843
Operating Income
21,632
21,632
-39,365
-58,374
-64,915
Net Non Operating Interest Income Expense
-23,410
-23,410
-19,234
-13,022
-11,697
Other Income Expense
-26,461
-26,461
-7,305
-252
863.269
Pretax Income
-28,239
-28,239
-65,904
-71,648
-75,749
Net Income Common Stockholders
-28,239
-28,239
-65,904
-71,648
-75,749
Diluted NI Available to Com Stockholders
-28,239
-28,239
-65,904
-71,648
-75,749
Basic EPS
-0.11
-
-0.33
-0.51
-0.88
Diluted EPS
-0.11
-
-0.33
-0.51
-0.88
Basic Average Shares
218,201
-
197,875
139,579
86,145
Diluted Average Shares
218,201
-
197,875
139,579
86,145
Total Operating Income as Reported
21,632
21,632
-39,365
-58,374
-64,915
Total Expenses
236,583
236,583
193,445
139,317
107,135
Net Income from Continuing & Discontinued Operation
-28,239
-28,239
-65,904
-71,648
-75,749
Normalized Income
-2,065
-2,065
-59,234
-71,648
-76,740
Interest Income
1,617
1,617
45
35
288.126
Interest Expense
25,027
25,027
19,279
13,057
11,985
Net Interest Income
-23,410
-23,410
-19,234
-13,022
-11,697
EBIT
-3,212
-3,212
-46,625
-58,591
-63,763
EBITDA
5,120
5,120
-39,512
-53,095
-59,821
Reconciled Cost of Revenue
161,665
161,665
112,417
74,989
58,064
Reconciled Depreciation
8,332
8,332
7,113
5,496
3,942
Net Income from Continuing Operation Net Minority Interest
-28,239
-28,239
-65,904
-71,648
-75,749
Total Unusual Items Excluding Goodwill
-26,174
-26,174
-6,670
0
991.797
Total Unusual Items
-26,174
-26,174
-6,670
0
991.797
Normalized EBITDA
31,294
31,294
-32,842
-53,095
-60,813
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0